Cetirizine Hydrochloride Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Cetirizine Hydrochloride Market covers analysis By Dosage Form (Syrup, Tablet, Solution); Age Group (Adult, Pediatric); Application (Allergic Rhinitis, Allergic Conjunctivitis, Eczema, Others); Distribution (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00027678
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET OVERVIEW


Cetirizine Hydrochloride is a second-generation antihistamine drug used to treat allergic rhinitis, dermatitis, and urticaria. Cetirizine is used to temporarily relieve the symptoms of hay fever i.e. allergy to pollen, dust, or other substances in the air and allergy to other substances such as dust mites, animal dander, cockroaches, and molds.

MARKET SCOPE


The "Global Cetirizine Hydrochloride Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Cetirizine Hydrochloride market with detailed market segmentation by dosage form, age group, application, and distribution channel. The report provides key statistics on the market status of the leading Cetirizine Hydrochloride market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  •   Based on dosage form the market is segmented as, syrup, tablet, and solution.
  •   Based on the age group the market is segmented as, adult and pediatric.
  •   Based on application the market is segmented as, allergic rhinitis, allergic conjunctivitis, eczema, and others.
  •   Based on distribution the market is segmented as, hospital pharmacies, retail pharmacies, and online pharmacies.

MARKET DYNAMICS


Drivers:



  •   Rising prevalence of allergic rhinitis, dermatitis, urticaria, and other allergic disorders.
  •   Increased risks of developing allergic eye conditions.

Restraints:



  •   Side effects such as Insomnia, hyperactivity, uneven heartbeat, nausea, constipation, and headache.
  •   Whereas, high cost of treatment for SBS is expected to restrain the market growth during the forecast period.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 concerning five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South and Central America. The Cetirizine Hydrochloride market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South and Central America after evaluating political, economic, social, and technological factors affecting the Cetirizine Hydrochloride market in these regions.

IMPACT OF COVID-19 ON CETIRIZINE HYDROCHLORIDE MARKET


COVID-19 first began in Wuhan (China) in December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in the global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS


The report covers key developments in the Cetirizine Hydrochloride market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships & collaborations. These activities have paved the way for the expansion of business and the customer base of market players. The market payers from the Cetirizine Hydrochloride market are anticipated to lucrative growth opportunities in the future with the rising demand for Cetirizine Hydrochloride in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Cetirizine Hydrochloride market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   JOHNSON AND JOHNSON
  •   MYLAN, INC.
  •   NICOX S.A.
  •   STRIDES SHASUN, APOTEX, INC.
  •   TEVA UK LIMITED
  •   AUROBINDO PHARMA LIMITED
  •   JUBILANT LIFE SCIENCES
  •   TRIS PHARMA, INC.
  •   CIPLA LTD.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Cetirizine Hydrochloride Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Dosage Form
  • Syrup
  • Tablet
  • Solution
By Age Group
  • Adult
  • Pediatric
By Application
  • Allergic Rhinitis
  • Allergic Conjunctivitis
  • Eczema
By Distribution
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Johnson and Johnson
  • Mylan, Inc.
  • Nicox S.A.
  • Strides Shasun, Apotex, Inc.
  • Teva UK Limited
  • Aurobindo Pharma Limited
  • Jubilant Life Sciences
  • Tris Pharma, Inc.
  • Cipla Ltd.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1.Johnson and Johnson
    2.Mylan, Inc.
    3.Nicox S.A.
    4.Strides Shasun, Apotex, Inc.
    5.Teva UK Limited
    6.Aurobindo Pharma Limited
    7.Jubilant Life Sciences
    8.Tris Pharma, Inc.
    9.Cipla Ltd.

    Buy Now